Edition:
India

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

102.19USD
1 Dec 2020
Change (% chg)

$-0.92 (-0.89%)
Prev Close
$103.11
Open
$103.85
Day's High
$104.40
Day's Low
$101.93
Volume
253,865
Avg. Vol
283,506
52-wk High
$110.96
52-wk Low
$72.20

Summary

Name Age Since Current Position

Steven Collis

58 2016 Chairman of the Board, President, Chief Executive Officer

James Cleary

56 2018 Chief Financial Officer, Executive Vice President

Silvana Battaglia

52 2019 Chief Human Resource Officer, Executive Vice President

Gina Clark

62 2017 Executive Vice President, Chief Communications & Administration Officer

John Chou

63 2019 Executive Vice President, Chief Legal Officer and Secretary

Leslie Donato

50 2019 Executive Vice President and Chief Strategy Officer

Robert Mauch

52 2019 Executive Vice President and Group President

Lonie Haynes

2020 Senior Vice President, Chief Diversity and Inclusion Officer

Jane Henney

72 2016 Lead Independent Director

Ornella Barra

66 2015 Director

D. Mark Durcan

58 2015 Independent Director

Richard Gochnauer

70 2008 Independent Director

Lon Greenberg

69 2013 Independent Director

Kathleen Hyle

61 2010 Independent Director

Michael Long

61 2006 Independent Director

Henry McGee

66 2004 Independent Director

Dennis Nally

67 2020 Independent Director

Biographies

Name Description

Steven Collis

Mr. Steven (Steve) H. Collis serves as Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Collis is the President and Chief Executive Officer of AmerisourceBergen Corporation and has served in this position since July 2011. He has been a member of our Board since 2011 and has served as our Board's Chairman since March 2016. From November 2010 to July 2011, Mr. Collis served as President and Chief Operating Officer of AmerisourceBergen Corporation. He served as Executive Vice President and President of AmerisourceBergen Drug Corporation from September 2009 to November 2010, as Executive Vice President and President of AmerisourceBergen Specialty Group from September 2007 to September 2009 and as Senior Vice President of AmerisourceBergen Corporation and President of AmerisourceBergen Specialty Group from August 2001 to September 2007. Mr. Collis has held a variety of other positions with AmerisourceBergen Corporation and its predecessors since 1994. Mr. Collis is a member of the Board of CEOs Against Cancer (PA Chapter), and is a member of the American Red Cross Board of Governors. He previously served on the Board of International Federation of Pharmaceutical Wholesalers, Inc. until October 2018 and the board of Thoratec Corporation from 2008 to 2015.

James Cleary

Mr. James F. Cleary Jr. serves as Chief Financial Officer, Executive Vice President of the Company. Mr. Cleary has been Executive Vice President since March 2015 and became Group President, Global Commercialization Services & Animal Health in June 2017. He served as President, MWI Veterinary Supply from March 2015 to June 2017. Prior to joining the Company, he was President and Chief Executive Officer of MWI Veterinary Supply, Inc. from June 2002.

Silvana Battaglia

Ms. Silvana Battaglia serves as Chief Human Resource Officer, Executive Vice President of the Company. Ms. Battaglia brings with her more than two decades of experience running international human resources organizations for Fortune 500 companies, helping to successfully shape company design, diversity and inclusion, workforce planning and more. Most recently at Aramark, Battaglia set strategic direction, designed and implemented solutions to improve employee engagement across 22 countries and developed workforce strategies to enable business growth and increase competitiveness. Throughout her tenure, Battaglia has developed expertise in developing high-performing employees, shaping company culture and driving organizational effectiveness.

Gina Clark

Ms. Gina K. Clark serves as Executive Vice President, Chief Communications & Administration Officer of the Company. She served as Chief Marketing Officer from November 2014 to June 2017. Ms. Clark was named Senior Vice President and Chief Marketing Officer in June 2011. She previously served as Senior Vice President of Marketing and Business Development for AmerisourceBergen Specialty Group from January 2007 to June 2011. Prior to joining the Company, she worked in executive leadership roles at Premier Inc. and HealthSouth, including Senior Vice President of Marketing and Alliance Relations, Group Vice President of Relationship Management, and Senior Vice President of Managed Care and National Contracting.

John Chou

Mr. John G. Chou serves as Executive Vice President, Chief Legal Officer and Secretary of the Company. Mr. Chou has been Executive Vice President since August 2011 and became the Chief Legal Officer and Secretary in September 2019. He served as Chief Legal & Business Officer of the Company from May 2017 to September 2019. He served as General Counsel of the Company from January 2007 to June 2017. From January 2007 to August 2011, Mr. Chou was a Senior Vice President. He served as Secretary of the Company from February 2006 to May 2012. He was Vice President and Deputy General Counsel from November 2004 to January 2007 and Associate General Counsel from July 2002 to November 2004. Mr. Chou has been employed by the Company for 17 years.

Leslie Donato

Ms. Leslie E. Donato serves as Executive Vice President and Chief Strategy Officer of the Company. She brings nearly 30 years of long-range strategy and healthcare industry experience. Most recently at Bayer Pharmaceuticals, Ms. Donato developed an integrated global pharmaceutical strategy and a U.S. growth strategy, oversaw the U.S. business for both hematology and neurology, and led the global strategic marketing team for neurology. Prior to Bayer, Ms. Donato was a Partner at McKinsey & Company specializing in healthcare. Throughout her tenure, Ms. Donato has developed extensive expertise in understanding global business development, accelerating strategic growth, driving company transformation and re-design and empowering employee engagement.

Robert Mauch

Dr. Robert P. Mauch Ph.D. serves as Executive Vice President and Group President of the Company. He served as President, AmerisourceBergen Drug Corporation from February 2015 to June 2017. Mr. Mauch previously served as Senior Vice President Chief Operating Officer, AmerisourceBergen Drug Corporation from March 2014 to February 2015. He was Senior Vice President, Operations, AmerisourceBergen Drug Corporation from April 2012 to March 2014. He was Senior Vice President of Sales and Marketing, AmerisourceBergen Drug Corporation from April 2011 to April 2012. He was Senior Vice President, Alternate Care Sales and Marketing, AmerisourceBergen Drug Corporation from May 2010 to April 2011. Mr. Mauch has been employed by the Company or one of its predecessors for 25 years.

Lonie Haynes

Dr. Lonie Haynes serves as Senior Vice President, Chief Diversity and Inclusion Officer of the Company. Dr. Haynes will play a central role in fostering a culture of inclusion and positioning the company for accelerated business impact in a changing, globally diverse environment. With a Board of Directors that has included representation of women for nearly 20 years and people of color for more than 15 years, and a global workforce that is 56 percent female, an executive management committee with 43 percent female representation and 51 percent of individuals in the U.S. who disclose as people of color, Dr. Haynes will be in a strong position to mobilize the power of our workforce through diversity and inclusion best practices and drive sustainable growth. Dr. Haynes holds an undergraduate degree in political science and economics from the State University of New York at Albany (SUNY). Additionally, he holds post graduate degrees in Management (M.Sc.) from Boston University, an M.P.A with concentrations in philanthropy and public health from Baruch College at the City University of New York (CUNY) and in 2012 he was awarded a doctorate in law and policy (DL.P.) with distinction from Northeastern University. He is a member of the American College of Healthcare Executives (ACHE), the National Association of Health Services Executives (NAHSE) and is a national board member for the American Association of People with Disabilities.

Jane Henney

Dr. Jane E. Henney M.D. serves as Lead Independent Director of the Company. She has served as Home Secretary for the National Academy of Medicine since April 1, 2014. Dr. Henney was a Professor of Medicine at the College of Medicine at the University of Cincinnati from January 2008 until December 2012. She served as Senior Vice President and Provost for Health Affairs at the University of Cincinnati from July 2003 to January 2008 and was the Commissioner of Food and Drugs at the United States Food and Drug Administration from 1998 to 2001. Dr. Henney served as Vice President for Health Sciences at the University of New Mexico from 1994 to 1998. Dr. Henney previously served as a director of CIGNA Corporation from April 2004 until April 2018, AstraZeneca PLC from September 2001 to April 2011, Cubist Pharmaceuticals, Inc. from March 2012 to January 2014 and The China Medical Board from July 2004 until June 2019. Dr. Henney is a National Association of Corporate Directors (NACD) Board Leadership Fellow. Dr. Henney is a former member of the Board of The Commonwealth Fund and The Monnell Center for the Chemical Senses.

Ornella Barra

Ms. Ornella Barra serves as Director of the Company. Ms. Barra has served on our Board since January 2015 and currently serves as Co-Chief Operating Officer of Walgreens Boots Alliance, Inc. Previously, she served as Executive Vice President of Walgreens Boots Alliance, Inc. and President and Chief Executive of Global Wholesale and International Retail from February 2015 until June 2016. Ms. Barra served as Chief Executive, Wholesale and Brands of Alliance Boots GmbH from September 2013 until January 2015 and as Chief Executive of the Pharmaceutical Wholesale Division of Alliance Boots GmbH from January 2009 until September 2013. Prior to her role as Chief Executive of the Pharmaceutical Wholesale Division, Ms. Barra was the Wholesale and Commercial Affairs Director and a Board member of Alliance Boots plc. Prior to the merger of Alliance UniChem Plc and Boots Group plc, Ms. Barra was Executive Director of Alliance UniChem Plc, having been appointed to its Board in 1997 when Alliance Sante merged with UniChem Plc. Ms. Barra has been a member of Board of Directors of Assicurazioni Generali, one of the largest Italian insurance companies, since April 2013 and is an honorary Professor of the University of Nottingham's School of Pharmacy. Ms. Barra was a member of the Board of Directors of Alliance Boots GmbH between June 2007 and February 2015 and was Chairman of its Corporate Social Responsibility Committee from 2009 to 2014. She served as a member of the Board of International Federation of Pharmaceutical Wholesalers, Inc., and has been Chairman, since October 2014. Ms. Barra is a member of the Board of Efficient Consumer Response Europe.

D. Mark Durcan

Mr. D. Mark Durcan is an Independent Director of the Company. He served as Chief Executive Officer and Director of Micron Technology, Inc. from February 2012 until his retirement in May 2017. Mr. Durcan served in a variety of roles at Micron Technology, Inc., including as President and Chief Operating Officer from June 2007 to February 2012, and as Chief Technology Officer from June 1997 to February 2006. Between 1984 and February 2006, Mr. Durcan held various other positions with Micron Technology, Inc. and its subsidiaries and served as an officer from 1996 through his retirement. Mr. Durcan served as a director of MWI Veterinary Supply, Inc. from March 2014 until its acquisition by AmerisourceBergen in February 2015. Mr. Durcan has been a director for St. Luke's Health System of Idaho since February 2017. He also has served as a director for Advanced Micro Devices since October 2017 and for Veoneer since April 2018. He served as a director at Freescale Semiconductor, Inc. from 2014 through 2015. Mr. Durcan has also served on the Semiconductor Industry Association Board and the Technology CEO Council.

Richard Gochnauer

Mr. Richard (Dick) W. Gochnauer is an Independent Director of the Company. Mr. Gochnauer has served on our Board since September 2008. He served as Chief Executive Officer of United Stationers Inc. from December 2002 until his retirement in May 2011 and as Chief Operating Officer of United Stationers Inc. from July 2002 to December 2002. Mr. Gochnauer served as Vice Chairman and President, International, and President and Chief Operating Officer of Golden State Foods Corporation from 1994 to 2002. He currently serves as a member of the Boards of UGI Corporation, Golden State Foods Corporation, Vodori Inc., and Rush University Medical Center and previously served as a director of Fieldstone Communities, Inc. from 2000 to 2008 and United Stationers Inc. from July 2002 to May 2011. Mr. Gochnauer is also a member of the Center for Higher Ambition Leadership.

Lon Greenberg

Mr. Lon R. Greenberg is an Independent Director of the Company. He served as Chairman of UGI Corporation's Board of Directors from 1996 until January 2016 and as director of UGI Utilities, Inc. and AmeriGas Propane, both UGI Corporation subsidiaries. Mr. Greenberg served as Chief Executive Officer of UGI Corporation from 1995 until his retirement in April 2013. Mr. Greenberg served in various leadership positions throughout his tenure with UGI Corporation. He is a member of the Board of Directors of Ameriprise Financial, Inc. and the Board of Directors of the United Way of Greater Philadelphia and Southern New Jersey. Mr. Greenberg is a member of the Board of Trustees of Temple University and the Board of The Philadelphia Foundation and previously served as Chairman of the Board of Directors of Temple University Health System and as a member of the Board of Directors of Fox Chase Cancer Center. Mr. Greenberg previously served as a member of the Board of Aqua America, Inc.

Kathleen Hyle

Ms. Kathleen (Kathi) W. hyle is an Independent Director of the Company. She served as Senior Vice President of Constellation Energy and Chief Operating Officer of Constellation Energy Resources from November 2008 until March 2012. Ms. Hyle served as Chief Financial Officer for Constellation Energy Nuclear Group and for UniStar Nuclear Energy, LLC from June 2007 to November 2008. Prior to joining Constellation Energy in 2003, Ms. Hyle served as the Chief Financial Officer of ANC Rental Corp., Vice President and Treasurer of Auto-Nation, Inc., and Vice President and Treasurer of Black & Decker Corporation. She is the Chair of the Board of Bunge Limited and a member of the Board of Trustees of Center Stage in Baltimore, MD. Ms. Hyle is a member in WKW LLC, a limited liability company and is a former member of the Board of Sponsors for the Loyola University Maryland Sellinger School of Business and Management.

Michael Long

Mr. Michael (Mike) J. Long is an Independent Director of the Company. He has served as the Chief Executive Officer of Arrow Electronics, Inc. since May 2009 and as Chairman of the Board since 2010. Previously, he served as President and Chief Operating Officer of Arrow Electronics, Inc. from February 2008 until May 2009 and as a Senior Vice President of Arrow Electronics, Inc. from January 2006 to February 2008. Since 2018, he has served as a member of the Board of Directors of UCHealth and of National Western Stock Show. He served as a member of the Board of Trustees of the Denver Zoo from 2010 until 2017.

Henry McGee

Mr. Henry Wadsworth McGee III serves as Independent Director of the Company. He is a Senior Lecturer at Harvard Business School, a position he has held since July 2013. From April 2013 to August 2013, Mr. McGee served as a Consultant at HBO Home Entertainment. Previously, Mr. McGee served as President of HBO Home Entertainment from 1995 until his retirement in March 2013. He served as Senior Vice President, Programming, HBO Video, from 1988 to 1995 and prior to that, Mr. McGee served in leadership positions in various divisions of HBO. Mr. McGee is the former President of the Alvin Ailey Dance Theater Foundation and the Film Society of Lincoln Center. He has served on the Boards of the Sundance Institute, the Public Theater, Save the Children and the Time Warner Foundation. He is currently a member of the Board of Tegna Inc., the Pew Research Center and the Black Filmmaker Foundation. He was recognized by Savoy Magazine in 2016 and 2017 as a member of the Power 300 list of the Most Influential Black Corporate Directors. In 2018, the National Association of Corporate Directors named Mr. McGee to the Directorship 100, the organization's annual recognition of the country's most influential boardroom members.

Dennis Nally

Mr. Dennis M. Nally serves as Independent Director of the Company. Mr. Nally joined our Board in January 2020. He served as Chairman of PricewaterhouseCoopers International Ltd., the coordinating and governance entity of the PwC network, from 2009 to 2016. From 2002 to 2009, he served as Chairman and Senior Partner of the U.S. firm PricewaterhouseCoopers LLP. He joined PricewaterhouseCoopers LLP in 1974 and became partner in 1985, serving in numerous leadership positions within the organization, including National Director of Strategic Planning, Audit and Business Advisory Services Leader and Managing Partner. Mr. Nally is a member of the board of Morgan Stanley and Globality, Inc.

Basic Compensation

Name Fiscal Year Total

Steven Collis

11,309,900

James Cleary

3,453,480

Silvana Battaglia

--

Gina Clark

2,366,190

John Chou

3,508,620

Leslie Donato

--

Robert Mauch

3,537,600

Lonie Haynes

--

Jane Henney

332,582

Ornella Barra

--

D. Mark Durcan

281,320

Richard Gochnauer

295,070

Lon Greenberg

298,750

Kathleen Hyle

281,320

Michael Long

300,070

Henry McGee

305,947

Dennis Nally

--
As Of  30 Sep 2019